Atractylenolide I
APC-319
Atractylenolide I
Cat. No.
APC-319
CAS No.
73069-13-3
MF
C15H18O2
MW
230.3022
Atractylenolide I is a sesquiterpene derived from the rhizome of Atractylodes macrocephala and acts as a TLR4-antagonizing agent.
Need help? Our team of experienced experts is here for you with full support.
Technical Data
Description
Storage and Shipping
References
Product Name
CAS No.
73069-13-3
MF
C15H18O2
MW
230.3022
Specification
98%
Research Area
Neuroprotective, anti-allergic, anti-inflammatory
Description
Atractylenolide I is a sesquiterpene derived from the rhizome of Atractylodes macrocephala and acts as a TLR4-antagonizing agent. Packing: 10mg, 20mg, 50mg, 100mg, 500mg, 1g, 5g, 10g Availability: In stock
Storage and Shipping
Store under frozen or refrigerated conditions, keep away from strong light and heat
References
[1]. Atractylenolide I, et al. The JAK2/STAT3 pathway is involved in the anti-melanoma effects of atractylenolide I. Exp Dermatol. 2018 Feb;27(2):201-204.
[2]. Gao H, et al. Anti-depressant-like effect of atractylenolide I in a mouse model of depression induced by chronic unpredictable mild stress. Exp Ther Med. 2018 Feb;15(2):1574-1579.
[3]. Li W, et al. Atractylenolide I restores HO-1 expression and inhibits Ox-LDL-induced VSMCs proliferation, migration and inflammatory responses in vitro. Exp Cell Res. 2017 Apr 1;353(1):26-34.
[4]. Huang JM, et al. Atractylenolide-I sensitizes human ovarian cancer cells to paclitaxel by blocking activation of TLR4/MyD88-dependent pathway. Sci Rep. 2014 Jan 23;4:3840.
Disclaimer
This product is intended solely for scientific research or regulatory filing purposes. We do not provide products or services to individuals, please strictly comply with all applicable laws, regulations, and the committed use. Use for any other purpose is strictly prohibited.
Related Products
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.